Case Details
- Citation: [2024] SGHC 284
- Title: Public Prosecutor v Iswan bin Ali
- Court: High Court (General Division)
- Case Number: Criminal Case No 4 of 2024
- Date of Decision: 6 November 2024
- Hearing Dates: 17 September 2024; 1 October 2024
- Judge: Dedar Singh Gill J
- Plaintiff/Applicant: Public Prosecutor
- Defendant/Respondent: Iswan bin Ali (“Iswan”)
- Legal Area: Criminal Procedure and Sentencing
- Statutes Referenced: Misuse of Drugs Act (Cap 185, 2008 Rev Ed) (“MDA”); Criminal Procedure Code 2010 (2020 Rev Ed) (“CPC”)
- Key Provisions: MDA ss 5(1)(a), 5(2), 33(1), 33B(1)–(3); CPC s 128(1); CPC s 227(3)
- Judgment Length: 10 pages; 2,491 words
- Procedural Posture: Decision on sentence following conviction on an altered charge; guilty plea; determination whether offender qualifies as a “courier” under s 33B
Summary
In Public Prosecutor v Iswan bin Ali ([2024] SGHC 284), the High Court considered the mandatory sentencing framework for trafficking diamorphine under the Misuse of Drugs Act (MDA) and, critically, whether the accused could obtain statutory sentencing relief as a “mere courier” under s 33B. The court had previously altered the charge after finding reasonable doubt on certain possession-for-trafficking allegations, and Iswan then pleaded guilty to the altered charge.
The court convicted Iswan on the altered charge and proceeded to sentencing. Because the quantity of diamorphine exceeded the statutory threshold for mandatory death under the relevant trafficking provisions, the default position was the mandatory death penalty. However, the court examined whether Iswan satisfied the restrictive “courier” criteria in s 33B(2), which would permit a sentence of life imprisonment with caning (or, in other circumstances, imprisonment). The court held that Iswan was not a courier, primarily because his involvement extended beyond transporting or delivering drugs: he had sourced the drugs from a supplier and had the ability to determine the price paid by the principal, indicating participation in the drug distribution network rather than mere delivery.
What Were the Facts of This Case?
Iswan faced an initial charge of trafficking not less than 61.19g of diamorphine under s 5(1)(a) read with s 5(2) of the MDA. The evidence involved multiple “Drug Exhibits” (including Exhibits A1A1A, A1A2A, A1A3A and B1A1) and additional exhibits (Exhibits C1A and C1B) whose possession for the purpose of trafficking was contested. On 17 September 2024, the judge found that 51.41g of diamorphine in the Drug Exhibits was in Iswan’s possession for the purpose of trafficking. However, because Iswan raised sufficient doubt regarding whether Exhibits C1A and C1B were in his possession for trafficking, the court exercised its power under s 128(1) of the CPC to alter the charge.
The altered charge alleged that on 9 April 2020, at about 12.45 a.m., in a Singapore registered car (plate number SJL 6639L) parked at the open carpark of Blk 90 Pipit Road, Singapore, Iswan trafficked a Class A controlled drug by having in his possession for the purpose of trafficking four packets containing not less than 1843.8 grams of granular/powdery substance, which was analysed to contain not less than 51.41 grams of diamorphine. The charge was brought under s 5(1)(a) read with s 5(2) and punishable under s 33(1) of the MDA.
After the alteration, both the prosecution and defence indicated they did not wish to call additional witnesses or recall any witness regarding the altered charge. The matter was adjourned for Iswan to consider his plea and for further submissions on whether he could be treated as a “courier” under s 33B of the MDA. Iswan pleaded guilty to the altered charge. The court then, consistent with the CPC’s safeguards for offences punishable with death, ensured that the prosecution’s evidence and the court’s findings proved the altered charge beyond a reasonable doubt, leading to conviction.
For sentencing, the central factual dispute became not the fact of trafficking (which was established by conviction), but the scope of Iswan’s role. The defence maintained that the Drug Exhibits belonged to a person known as Zahari bin Samat (“Zahari” or “Bob”), who instructed Iswan to keep the drugs for delivery to third parties. On that account, Iswan’s role was limited to delivering the drugs and incidental safekeeping pending delivery, and he did not engage in activities such as dividing or repacking the drugs.
The prosecution’s case on sentencing was that Iswan was not a mere courier. It argued that Iswan’s account of ownership and purpose shifted during investigations and trial. Even accepting Iswan’s final version—that he held the drugs for Zahari—prosecution contended that Iswan had sourced the drugs from his supplier (Joe Cartel) and had the ability to determine the price Zahari would pay. Those features, the prosecution submitted, placed Iswan beyond the narrow statutory definition of a courier.
What Were the Key Legal Issues?
The first legal issue was the sentencing consequence of trafficking diamorphine above the statutory threshold. Under the MDA, trafficking more than 15g of diamorphine under s 5(1)(a) attracts the mandatory death penalty pursuant to s 33, read with the Second Schedule. This created a baseline of death unless the accused could bring himself within the statutory “courier” relief regime under s 33B.
The second, and determinative, legal issue was whether Iswan qualified as a “courier” under s 33B(2). That provision requires the accused to prove, on a balance of probabilities, that his involvement was restricted to transporting, sending, delivering, or acts preparatory to or for those purposes. The court also emphasised that the definition is “tightly-defined” and interpreted narrowly, and that the statutory relief does not apply where the accused’s involvement extends beyond mere transport/delivery—even if the involvement is ancillary in nature.
A further related issue concerned the evidential and substantive content of Iswan’s role. The court had to decide whether the defence’s narrative of incidental safekeeping for delivery was credible and legally sufficient, or whether Iswan’s conduct—particularly sourcing the drugs and influencing pricing—meant he was participating in the drug supply/distribution network rather than acting as a mere courier.
How Did the Court Analyse the Issues?
The court began by setting out the statutory sentencing architecture. It noted that trafficking more than 15g of diamorphine under s 5(1)(a) is punishable by the mandatory death penalty. The only route away from death, in the circumstances, was to satisfy the requirements of s 33B. The court observed that s 33B provides two alternative sentencing outcomes depending on which subsection applies. Since the defence did not allege any abnormality of mind, the only potentially relevant pathway was s 33B(2), which concerns “couriers”.
Under s 33B(2), two requirements must be met. First, the accused must prove on a balance of probabilities that his involvement was restricted to transporting/sending/delivering the controlled drug, offering to do so, or doing acts preparatory to or for those purposes. If satisfied, the accused is a “mere courier”. Second, the prosecution must issue a Certificate of Substantive Assistance (CSA). While the extract focuses heavily on the first requirement—whether Iswan was a courier—the court’s analysis reflects that the courier label is a threshold question that must be met before the CSA question becomes relevant.
In analysing whether Iswan was a courier, the court relied on binding Court of Appeal authority. It reiterated that the statutory relief under s 33B is intended to be “tightly-defined” and interpreted narrowly. The court cited Public Prosecutor v Chum Tat Suan and another ([2015] 1 SLR 834) for the proposition that it is “abundantly clear” the relief does not apply to those whose involvement extends beyond transporting/sending/delivering. The court emphasised the key doctrinal point: it does not matter if the accused’s involvement is ancillary; the statutory relief is available only where the accused is involved only in transporting/sending/delivering (and acts incidental or necessary thereto). The court also noted the caveat that mere incidental storage or safekeeping, in the course of transporting/sending/delivering, does not take the accused outside the courier definition.
Applying these principles, the court rejected the defence submission that Iswan’s role was limited to delivery and incidental safekeeping. The court found “clear evidence” that Iswan had sourced the drug exhibits from his supplier, Joe Cartel. This factual finding was supported by Iswan’s own investigation statements. In his 5th investigation statement, Iswan described a conversation with Zahari (Bob) about purchasing “panas” and explained that his supplier only sold in minimum quantities. He stated that Bob lacked sufficient money for the minimum quantity and that they agreed on a split: Bob would take three “batu” and Iswan would take two, with Iswan topping up the remaining amount. Iswan further stated that Bob passed cash to him and that Iswan would update Bob once he received the “panas”. In his 6th investigation statement, Iswan again described discussions with Bob about quantities and pricing, and that he placed an order with Joe Cartel after the conversation.
The court treated sourcing as legally significant. It reasoned that sourcing for the supply of drugs is “plainly very far removed” from the nature and objective of conveying drugs to a designated recipient. Instead, it concerns expansion of the drug distribution network and growth of drug sales. This reasoning was anchored in Zainudin bin Mohamed v Public Prosecutor ([2018] 1 SLR 449), where the Court of Appeal explained why sourcing is inconsistent with the courier concept. The court also drew support from Rosman bin Abdullah v Public Prosecutor ([2017] 1 SLR 10), where the Court of Appeal agreed that the appellant was not a courier because he had actively sourced for the drugs and participated in negotiations as a middleman or go-between regarding price and delivery terms.
Although Iswan’s case differed from Rosman in that the court’s extract suggests he may not have acted as a middleman in negotiations for price in the same way, the court found another decisive factor: Iswan had the ability to determine the price Zahari paid for the drugs. The court treated this as further evidence that Iswan’s role was not restricted to transporting or delivering, but involved participation in the commercial arrangements underpinning the drug transaction. The extract indicates that during cross-examination, the court confronted Iswan with inconsistencies in his explanations about selling “batu” to Bob versus giving the “batu”, and the handling of money allegedly meant to be returned to Joe Cartel as a loan. While the extract is truncated, the court’s conclusion is clear: Iswan’s involvement included sourcing and pricing influence, which are incompatible with the narrow courier definition.
Accordingly, the court held that Iswan was not a courier within s 33B(2). The legal consequence of failing the courier threshold was that the statutory relief from the mandatory death penalty was unavailable. The court’s analysis thus demonstrates how the courier doctrine operates as a strict gatekeeping mechanism: even where the accused claims he was merely holding drugs for delivery, conduct showing active procurement and pricing influence will generally disqualify the accused.
What Was the Outcome?
The court convicted Iswan of the altered charge of trafficking diamorphine under s 5(1)(a) read with s 5(2) and punishable under s 33(1) of the MDA. It then determined that Iswan did not qualify as a courier under s 33B(2). As a result, the court imposed the mandatory death penalty for the offence.
Practically, the decision confirms that where the accused’s role includes sourcing drugs from a supplier and influencing pricing, the court will likely find that the involvement extends beyond transporting/sending/delivering. This means the statutory sentencing relief for couriers will not be available, even if the accused did not physically divide or repack the drugs.
Why Does This Case Matter?
This case matters because it illustrates, in a sentencing context, the strict boundaries of the “courier” exception under Singapore’s MDA regime. The High Court’s reasoning aligns with the Court of Appeal’s jurisprudence that s 33B relief is not a general mitigation provision for low-level participants. Instead, it is a narrowly tailored statutory mechanism intended only for those whose role is confined to transporting, sending, delivering, or acts incidental or necessary to those functions.
For practitioners, the decision is a reminder that factual narratives about “holding for delivery” will be scrutinised against the accused’s investigative statements and the practical realities of involvement. Evidence that the accused sourced the drugs, placed orders, negotiated quantities, or had influence over pricing will likely be treated as participation in the drug distribution network. Defence counsel should therefore carefully evaluate whether the evidential record can support the balance-of-probabilities burden under s 33B(2), particularly on the “restricted involvement” requirement.
From a research perspective, the case is also useful for mapping how the courts apply Zainudin, Chum Tat Suan, and Rosman to concrete scenarios. It demonstrates that even if an accused does not act as a classic “middleman” in negotiations, sourcing and pricing influence can independently defeat courier status. The decision thus reinforces a consistent doctrinal approach: the courier exception is not about perceived culpability levels, but about the legally defined nature of the accused’s role.
Legislation Referenced
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed): ss 5(1)(a), 5(2), 33(1), 33B(1), 33B(2), 33B(3)
- Criminal Procedure Code 2010 (2020 Rev Ed): s 128(1), s 227(3)
Cases Cited
- Public Prosecutor v Chum Tat Suan and another [2015] 1 SLR 834
- Zainudin bin Mohamed v Public Prosecutor [2018] 1 SLR 449
- Rosman bin Abdullah v Public Prosecutor [2017] 1 SLR 10
- Public Prosecutor v Iswan bin Ali [2024] SGHC 239
Source Documents
This article analyses [2024] SGHC 284 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.